- Home
- ALT vs ABL Comparison
ALT vs ABL Comparison
Compare ALT & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | ABL |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 567.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALT | ABL |
|---|---|---|
| Price | $5.45 | $8.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $16.33 | $12.00 |
| AVG Volume (30 Days) | ★ 3.5M | 717.5K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $20,000.00 | ★ $196,551,131.00 |
| Revenue This Year | N/A | $95.83 |
| Revenue Next Year | N/A | $19.67 |
| P/E Ratio | ★ N/A | $69.99 |
| Revenue Growth | N/A | ★ 91.93 |
| 52 Week Low | $2.90 | $4.60 |
| 52 Week High | $9.59 | $9.61 |
Technical Indicators
Market Signals| Indicator | ALT | ABL |
|---|---|---|
| Relative Strength Index (RSI) | 62.89 | 74.75 |
| Support Level | $5.03 | $6.37 |
| Resistance Level | $6.03 | $8.56 |
| Average True Range (ATR) | 0.38 | 0.44 |
| MACD | -0.00 | 0.18 |
| Stochastic Oscillator | 55.52 | 91.03 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.